Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform 2017-08-22 04:48
Sorrento Therapeutics Announces the Completion of GMP Manufacturing Plant in Suzhou, China to Support its Growing Antibody-Drug Conjugate (ADC) Pipeline and Service Business 2017-05-04 22:17
Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics 2017-04-28 21:00
Sorrento and Wildcat Announce Resolution 2017-03-20 20:00
Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration Agreement for Development and Commercialization of Anti-PD-1 Antibody 2016-07-11 21:00
Sorrento Announces Definitive Agreements for up to $150 Million Private Placement 2016-04-05 08:55
NantWorks Acquires Cynviloq(TM) For Up To $1.3+ Billion 2015-05-15 21:00
Sorrento Announces Positive TRIBECA(TM) Registrational Study Results 2015-05-04 21:00
Sorrento and Conkwest Announce Exclusive Global Collaboration 2014-12-19 19:36
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel 2014-10-15 04:44
1